Coronavirus Notebook: EMA Begins Assessing AZ’s Evusheld, Apeiron Starts Phase I Trial Of Inhaled APN01

Inhaler
Apeiron Biologics is trialing an inhaled product for COVID-19 • Source: Shutterstock

More from Europe

More from Geography